These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8860681)

  • 21. [Superparamagnetic iron oxide particles: current state and future development].
    Taupitz M; Schmitz S; Hamm B
    Rofo; 2003 Jun; 175(6):752-65. PubMed ID: 12811686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil.
    Jung CW
    Magn Reson Imaging; 1995; 13(5):675-91. PubMed ID: 8569442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long circulating superparamagnetic particles with high T2 relaxivity.
    Pochon S; Hyacinthe R; Terrettaz J; Robert F; Schneider M; Tournier H
    Acta Radiol Suppl; 1997; 412():69-72. PubMed ID: 9240083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience.
    Bellin MF; Roy C; Kinkel K; Thoumas D; Zaim S; Vanel D; Tuchmann C; Richard F; Jacqmin D; Delcourt A; Challier E; Lebret T; Cluzel P
    Radiology; 1998 Jun; 207(3):799-808. PubMed ID: 9609907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged in vivo circulation time by zwitterionic modification of magnetite nanoparticles for blood pool contrast agents.
    Xiao W; Lin J; Li M; Ma Y; Chen Y; Zhang C; Li D; Gu H
    Contrast Media Mol Imaging; 2012; 7(3):320-7. PubMed ID: 22539402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In situ analysis of a bimodal size distribution of superparamagnetic nanoparticles.
    Thünemann AF; Rolf S; Knappe P; Weidner S
    Anal Chem; 2009 Jan; 81(1):296-301. PubMed ID: 19117457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis.
    Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS
    Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term investigation on the phase stability, magnetic behavior, toxicity, and MRI characteristics of superparamagnetic Fe/Fe-oxide core/shell nanoparticles.
    Masoudi A; Hosseini HR; Reyhani SM; Shokrgozar MA; Oghabian MA; Ahmadi R
    Int J Pharm; 2012 Dec; 439(1-2):28-40. PubMed ID: 23058926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of poly(ethylene glycol) coating on colloidal stability of superparamagnetic iron oxide nanoparticles as potential MRI contrast agent.
    Masoudi A; Madaah Hosseini HR; Shokrgozar MA; Ahmadi R; Oghabian MA
    Int J Pharm; 2012 Aug; 433(1-2):129-41. PubMed ID: 22579990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging.
    Chen YC; Chang WH; Wang SJ; Hsieh WY
    J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleophilic cross-linked, dextran coated iron oxide nanoparticles as basis for molecular imaging: synthesis, characterization, visualization and comparison with previous product.
    Borny R; Lechleitner T; Schmiedinger T; Hermann M; Tessadri R; Redhammer G; Neumüller J; Kerjaschki D; Berzaczy G; Erman G; Popovic M; Lammer J; Funovics M
    Contrast Media Mol Imaging; 2015; 10(1):18-27. PubMed ID: 24753451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maghemite nanoparticles protectively coated with poly(ethylene imine) and poly(ethylene oxide)-block-poly(glutamic acid).
    Thünemann AF; Schütt D; Kaufner L; Pison U; Möhwald H
    Langmuir; 2006 Feb; 22(5):2351-7. PubMed ID: 16489828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging.
    Weissleder R; Elizondo G; Wittenberg J; Rabito CA; Bengele HH; Josephson L
    Radiology; 1990 May; 175(2):489-93. PubMed ID: 2326474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood clearance of dextran magnetite particles determined by a noninvasive in vivo ESR method.
    Iannone A; Magin RL; Walczak T; Federico M; Swartz HM; Tomasi A; Vannini V
    Magn Reson Med; 1991 Dec; 22(2):435-42. PubMed ID: 1725919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies.
    Schoepf U; Marecos EM; Melder RJ; Jain RK; Weissleder R
    Biotechniques; 1998 Apr; 24(4):642-6, 648-51. PubMed ID: 9564539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and quantitation in rat tissues of the superparamagnetic magnetic resonance contrast agent dextran magnetite as demonstrated by electron spin resonance spectroscopy.
    Iannone A; Federico M; Tomasi A; Magin RL; Casasco A; Calligaro A; Vannini V
    Invest Radiol; 1992 Jun; 27(6):450-5. PubMed ID: 1376725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro stability analyses as a model for metabolism of ferromagnetic particles (Clariscan), a contrast agent for magnetic resonance imaging.
    Skotland T; Sontum PC; Oulie I
    J Pharm Biomed Anal; 2002 Apr; 28(2):323-9. PubMed ID: 11929675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of systems for targeting the regional lymph nodes for diagnostic imaging: in vivo behaviour of colloidal PEG-coated magnetite nanospheres in the rat following interstitial administration.
    Illum L; Church AE; Butterworth MD; Arien A; Whetstone J; Davis SS
    Pharm Res; 2001 May; 18(5):640-5. PubMed ID: 11465419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Toxicity of magnetite-dextran particles: morphological study].
    Okon EE; Pulikan D; Pereverzev AE; Kudriavtsev BN; Zhale P
    Tsitologiia; 2000; 42(4):358-66. PubMed ID: 10849930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging of abscesses using lipid-coated iron oxide particles.
    Chan TW; Eley C; Liberti P; So A; Kressel HY
    Invest Radiol; 1992 Jun; 27(6):443-9. PubMed ID: 1376724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.